TGC Ventures International, Inc. (TGVN) is a publicly traded company in the Healthcare sector, operating within the Medical - Distribution industry. The company is headquartered in Atlanta, GA, United States. The current CEO is Michael Woo.
TGVN has IPO date of 2014-11-03, listed on the Other OTC, a market capitalization of $120.00.
TGC Ventures International, Inc. operates early detection cancer clinics, using infra-red thermal imaging technology. The technology is used as diagnosis to determine structure changes in tissues to detect breast cancer. The company was formerly known as National Detection Clinics, Ltd. and changed its name to TGC Ventures International, Inc. in December 2005. TGC Ventures International, Inc. was incorporated in 2003 and is headquartered in Atlanta, Georgia.
